Impact of Pilates Exercises Added to Pelvic Floor Muscle Training and Sildenafil on Diabetic Erectile Dysfunction. (PilatesDED2025)
Pilates Exercises Added to Pelvic Floor Muscle Training and Sildenafil for Diabetic Erectile Dysfunction: A Randomized Controlled Trial
Erectile dysfunction (ED) has a prevalence of 52.5% in diabetic male patients, as described in a meta-analysis of 145 studies, including 88,577 men with type 1 and type 2 diabetes.
In men, ED can cause sexual dissatisfaction and distress, unsatisfactory relationships, and marital tension
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Pilates emerged as a method of rehabilitation during World War I, when Joseph Hubertus Pilates applied his knowledge to rehabilitate injured men. The popularity of the method grew most in the 1980. More recently, Pilates has been used resulting in improved fitness (flexibility, strength and balance) and body consciousness. The method features ground-based exercises created by Joseph Pilates.
Because most Pilates exercises are performed in conjunction with the recruitment of PF muscle fibres, many Pilates instructors believe that the method can produce a significant increase in the force or contractility of the muscles. Furthermore, if Pilates promotes an improvement in the functioning of the pelvic floor muscles (PFM), it may be an alternative for the treatment and prevention of pelvic floor dysfunction.
Up till now, no published trials about impact of Pilate exercises on diabetic erectile dysfunction.
A total of 60 patients (n=30 per group), diagnosed with diabetic erectile dysfunction in the past 6 months. Participants will be recruited from Benha University hospital and local andrology and urology clinics in benha and giza . Participants will be screened for eligibility prior to being enrolled in the study participating in the study assessments.
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Benha
-
Banhā, Benha, Egypt
- Outpatient clinic, faculty of Physical Therapy, Benha university
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Men aged 40-60 years.
- Married.
- Diagnosed with type 2 diabetes mellitus for >5 years, with initial diagnosis confirmed by HbA1c >6.5%.
- Arteriogenic erectile dysfunction (ED) of >6 months' duration, diagnosed using the International Index of Erectile Function-5 (IIEF-5),confirmed by penile Doppler ultrasonography showing peak systolic velocity (PSV) of the cavernosal arteries <25 cm/s.
- Body mass index (BMI) <30 kg/m².
Exclusion Criteria:
- Poorly controlled diabetes mellitus (HbA1c >9%).
- Neurogenic, venogenic, or psychogenic ED.
- Cardiac conditions contraindicating sexual activity.
- Neurological disorders or spinal cord injury.
- Alcohol abuse or illicit drug use.
- Chronic hematological disorders.
- Active genitourinary infection.
- Severe hypogonadism.
- History of radical prostatectomy, pelvic surgery, or pelvic trauma.
- Penile prosthesis implantation.
- Current or previous participation in a structured pelvic floor muscle training or sexual rehabilitation program.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Experimental
|
The program had 11 mat exercises: Pilates breathing, spine stretch, swan, shoulder bridge, hundreds, double leg stretch, footwork, roll up, single leg stretch, leg pull back, and kick front and back, It had three phases of four weeks each. In the beginner phase (weeks 1 to 4), participants did one set of six to eight repetitions of each exercise, using supported positions and modified movements to establish breathing coordination and lumbopelvic control. In the intermediate phase (weeks 5 to 8), they did two sets of eight to 10 repetitions with larger movement amplitude, longer lever arms, and more challenging limb movements. In the advanced phase (weeks 9 to 12), they did two sets of 10 to 12 repetitions of more complex variations with greater stabilization demands, provided they kept adequate movement control. Participants attended an educational session conducted by a physiotherapist covering pelvic floor anatomy, the physiology of erection, and the roles of the ischiocavernosus and bulbocavernosus muscles in erectile function. They were instructed on proper pelvic floor muscle contraction using simulated interruption of urine flow and maximal voluntary contractions. A home-based PFMT program was prescribed, initially performed in the supine position with knees flexed and subsequently progressed to sitting or standing positions as tolerated. Participants were instructed to perform PFMT twice daily (morning and evening), consisting of 15 short contractions (1 second each) and 15 sustained contractions (6-10 seconds each). Adherence was monitored through a mobile messaging application, via which participants reported completion of their daily exercises and received reminders when necessary. Participants received sildenafil citrate 25 mg orally once daily and sildenafil citrate 50 mg orally on demand, taken approximately 1 hour before sexual intercourse, throughout the study period. |
|
Active Comparator: Active comparator
|
Participants attended an educational session conducted by a physiotherapist covering pelvic floor anatomy, the physiology of erection, and the roles of the ischiocavernosus and bulbocavernosus muscles in erectile function. They were instructed on proper pelvic floor muscle contraction using simulated interruption of urine flow and maximal voluntary contractions. A home-based PFMT program was prescribed, initially performed in the supine position with knees flexed and subsequently progressed to sitting or standing positions as tolerated. Participants were instructed to perform PFMT twice daily (morning and evening), consisting of 15 short contractions (1 second each) and 15 sustained contractions (6-10 seconds each). Adherence was monitored through a mobile messaging application, via which participants reported completion of their daily exercises and received reminders when necessary. Participants received sildenafil citrate 25 mg orally once daily and sildenafil citrate 50 mg orally on demand, taken approximately 1 hour before sexual intercourse, throughout the study period. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
International Index of Erectile Function-5 (IIEF-5) scale.
Time Frame: Baseline and after 12 weeks
|
The IIEF-5 scale is used to assess patients with erectile dysfunction to determine the extent of the erectile function in patients. The full-scale 15-item version has five domains: erectile function, orgasmic function, sexual desire, intercourse satisfaction and overall sexual satisfaction. The shortened 5-item version is on a scale of 5 to 25: 22-25: No erectile dysfunction 17-21: Mild erectile dysfunction 12-16: Mild to moderate erectile dysfunction 8-11: Moderate erectile dysfunction 5-7: Severe erectile dysfunction |
Baseline and after 12 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
penile perfusion
Time Frame: Base line and after 12 weeks
|
Colour-coded duplex sonography (5-10 MHz probes) will be used for the evaluation of penile perfusion. Half ml of a vasoactive agent (trimix solution) will be injected into the corpus cavernosum. The systolic and diastolic velocities (cm/s) will be performed at 10 and 30 min for both cavernous artery. Re-dosing with 0.5 ml of trimax solution will be performed for patients who did not achieve adequate hardness. The highest values obtained will be recorded. The Doppler indices of the right and left cavernous arteries: peak systolic velocity (PSV) |
Base line and after 12 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Urogenital Diseases
- Genital Diseases
- Endocrine System Diseases
- Mental Disorders
- Genital Diseases, Male
- Male Urogenital Diseases
- Metabolic Diseases
- Glucose Metabolism Disorders
- Sexual Dysfunction, Physiological
- Sexual Dysfunctions, Psychological
- Nutritional and Metabolic Diseases
- Diabetes Mellitus
- Erectile Dysfunction
- Therapeutics
- Physical Therapy Modalities
- Exercise Movement Techniques
Other Study ID Numbers
Other Study ID Numbers
- Pilate Exercises for DED2025
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.